The rise of Viagra initially drove a period of growth for pharma, however recent developments present a uncertain scenario for those considering a stake. Off-patent versions are eroding earnings, and persistent https://gregoryfdrj333975.answerblogs.com/41571460/sildenafil-and-big-pharma-a-risky-investment